Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LifeStance Health Gr Affirms FY2025 Sales Guidance of $1.400B-$1.440B vs $1.413B Est

Author: Benzinga Newsdesk | August 07, 2025 05:04am

2025 Guidance

LifeStance is providing the following outlook for 2025:

  • The Company is reiterating full year revenue of $1.40 billion to $1.44 billion; raising Center Margin to $441 million to $465 million; and raising Adjusted EBITDA to $140 million to $150 million.
  • For the third quarter of 2025, the Company expects total revenue of $345 million to $365 million, Center Margin of $105 million to $119 million, and Adjusted EBITDA of $33 million to $39 million.

Posted In: LFST


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist